Desperation showing again. I wonder if somehow word has
Desperation showing again. I wonder if somehow word has leaked out from a clinical trial, or maybe someone at a big pharma has disclosed information that they learned after signing a Non-Disclosure Agreement which was supposed to prevent info leakage.
Because the load of BS has gotten surprisingly high.
Anyone who thinks that a market cap of about 150 million is too high for a company with 5 clinical trials, involving 3 different drugs, for 5 different applications -- well, clearly that person is either very ignorant, or has an ulterior motive. Does anyone really think that that a company trying to find a better drug for h. pylori (the cause of stomach ulcers, which are already treatable with a cocktail of existing antibiotics) and Crohn's Disease (an unmet need -- but not an extremely common disease) should be valued more than CTIX, with its 5 clinical trials and 3 completely different drugs -- those clinical trials being for much more common diseases or treatment of a debilitating side effect of cancer treatment (Brilacidin-Oral Mucositis)?
Nonsensical comparisons and claims that CTIX is overvalued should be seen as what they are -- desperate acts of people who want to suppress the stock price. Whatever their reasons, it really is a waste of time and their employers' resources to keep posting nonsense here. Surely even the newest readers must recognize the foolishness of these attempts to bash the stock.
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...
Continue Reading
AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...
Continue Reading
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Recent Share Buybacks by Kaldalón hf. In week 37 of 2025, Kaldalón hf. successfully executed a buyback of its own shares, acquiring 780,000 in total for ISK 19,026,000. This strategic move is a part of the company's ongoing efforts to maintain a robust market presence and enhance shareholder value. Details of Share Transactions Transaction Insights The...
Continue Reading
Strong Q1 Performance and Financial Highlights Corby Spirit and Wine Limited (TSX: CSW.A, TSX: CSW.B), a prominent Canadian manufacturer and marketer of spirits and ready-to-drink beverages, has reported impressive financial results for the first quarter of fiscal 2026, demonstrating a robust growth trajectory. Remarkable Revenue Growth During the first quarter, Corby...
Continue Reading
All County Property Management Expands Service to New Area New Midlands office brings innovative, service-focused property management solutions to the region All County Property Management Franchise Corp. has unveiled its newest franchise office, named All County Specialists Property Management. This new office is set to serve the Columbia area, along with the broader...
Continue Reading
Understanding the Impact of Employee Leave Experiences Recent studies have highlighted an essential aspect of workforce management: the significant correlation between positive employee leave experiences and long-term employee retention. Companies that prioritize supportive leave policies can create a more loyal workforce, fostering morale and a sense of belonging among...
Continue Reading
Patrick Industries, Inc. Engages with Investors at Benchmark Conference Patrick Industries, Inc. (NASDAQ: PATK), a prominent component solutions provider for the outdoor enthusiast and housing markets, is set to make its mark at the upcoming Benchmark's 3rd Annual Consumer One-on-One Conference. This pivotal event is scheduled to take place soon, indicating Patrick's...
Continue Reading